- Home
- STRO vs XPER Comparison
STRO vs XPER Comparison
Compare STRO & XPER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- XPER
- Stock Information
- Founded
- STRO 2003
- XPER 1990
- Country
- STRO United States
- XPER United States
- Employees
- STRO N/A
- XPER N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- XPER Semiconductors
- Sector
- STRO Health Care
- XPER Technology
- Exchange
- STRO Nasdaq
- XPER Nasdaq
- Market Cap
- STRO 172.8M
- XPER 463.5M
- IPO Year
- STRO 2018
- XPER 2003
- Fundamental
- Price
- STRO $1.72
- XPER $8.94
- Analyst Decision
- STRO Strong Buy
- XPER Strong Buy
- Analyst Count
- STRO 7
- XPER 3
- Target Price
- STRO $12.14
- XPER $19.00
- AVG Volume (30 Days)
- STRO 1.1M
- XPER 370.6K
- Earning Date
- STRO 11-13-2024
- XPER 02-26-2025
- Dividend Yield
- STRO N/A
- XPER N/A
- EPS Growth
- STRO N/A
- XPER N/A
- EPS
- STRO N/A
- XPER N/A
- Revenue
- STRO $160,955,000.00
- XPER $508,559,000.00
- Revenue This Year
- STRO N/A
- XPER N/A
- Revenue Next Year
- STRO N/A
- XPER $2.28
- P/E Ratio
- STRO N/A
- XPER N/A
- Revenue Growth
- STRO 230.90
- XPER N/A
- 52 Week Low
- STRO $1.67
- XPER $6.89
- 52 Week High
- STRO $6.13
- XPER $12.29
- Technical
- Relative Strength Index (RSI)
- STRO 29.77
- XPER 33.78
- Support Level
- STRO $1.80
- XPER $8.82
- Resistance Level
- STRO $2.15
- XPER $10.62
- Average True Range (ATR)
- STRO 0.13
- XPER 0.31
- MACD
- STRO 0.03
- XPER -0.20
- Stochastic Oscillator
- STRO 10.42
- XPER 6.67
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About XPER Xperi Inc.
Xperi Inc consumer and entertainment technology company. Its offering comprises a portfolio of software and services. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment.